All lobbying filings

Capitol City Group, Ltd.

Capitol City Group, Ltd. filed a Q4 report for Ardelyx, Inc. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Ardelyx, Inc. · discovering, developing and commercializing medicine

As filed: CAPITOL CITY GROUP, LTD. for ARDELYX, INC.

All filings by Capitol City Group, Ltd. · Everything Ardelyx, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Assist client with matters re: kidney dialysis drugs and renal drugs; assist client with medicare/CMS issues; assist re: issues on ESRD related drugs and medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.